Enhance: Enhancing HIV Prevention by Using Behavioral Intervention Among HIV-Infected Men
Study Details
Study Description
Brief Summary
This study will evaluate the effectiveness of a behavioral intervention program versus standard prevention case management in promoting safer sex practices in HIV-infected men.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
In recent years, the spread of HIV and other STDs has increased, especially among men who have sex with men. This increase signifies continued sexual risk taking within this population. In order to curb the increase of HIV infections, prevention programs are needed. A standard prevention case management program has been developed; however, new programs that further improve outcomes are needed. This study will evaluate the effectiveness of a behavioral intervention program versus standard prevention case management (PCM) in promoting safer sex practices in HIV-infected men.
Participants in this 1-year open-label study will be randomly assigned to receive either PCM alone or a behavioral intervention called Project Enhance, in addition to PCM. The behavioral intervention will be administered by a trained medical social worker on an individual basis. It will include an education component, as well as motivational and behavioral skills enhancement. PCM will entail standard case management, as well as referrals to specific services that each individual may need. Treatment will occur for only the first 3 months, after which follow-up sessions will be held every 3 months for the remainder of the year.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Project Enhance Participants will receive the risk reduction program, Project Enhance |
Behavioral: Project Enhance
The behavioral intervention will be administered by a trained medical social worker on an individual basis. It will include an education component, as well as motivational and behavioral skills enhancement. Treatment will occur for only the first 3 months, after which follow-up sessions will be held every 3 months for the remainder of the year.
Other Names:
|
Active Comparator: Active Comparison Condition Participants will receive standard prevention case management |
Behavioral: Standard prevention case management (PCM)
Participants will receive standard PCM for HIV prevention.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Reduction in rates of unprotected anal intercourse from baseline to 12-month follow-up [Measured at Months 3, 6, 9, and 12]
Secondary Outcome Measures
- Incidence of sexually transmitted diseases [Measured at Months 3, 6, 9, and 12]
- Higher risk-reduction self-efficacy [Measured at Months 3, 6, 9, and 12]
- Increased behavioral intentions to engage in safer behaviors [Measured at Months 3, 6, 9, and 12]
- Increased risk-reduction strategies (other than condom use) [Measured at Months 3, 6, 9, and 12]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
HIV infected
-
Receives primary health care at Fenway Community Health
-
Identifies as a man who has sex with men
-
Has engaged in unprotected anal or vaginal intercourse within 3 months of study enrollment
Exclusion Criteria:
-
All episodes of unprotected anal intercourse occurred with only a single primary partner who is also HIV infected
-
Plans to relocate over the upcoming year
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Fenway Community Health | Boston | Massachusetts | United States | 02115 |
Sponsors and Collaborators
- Fenway Community Health
- National Institute of Mental Health (NIMH)
Investigators
- Principal Investigator: Kenneth Mayer, MD, Fenway Community Health and Brown University
- Principal Investigator: Steven Safren, PhD, Fenway Community Health and Harvard Medical School
- Study Director: Conall O'Cleirigh, PhD, Fenway Community Health and Massachusetts General Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- R01MH068746
- DAHBR 9A-ASPG
- R01MH068746